These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Exposure of cigarette smoke condensate activates NLRP3 inflammasome in THP-1 cells in a stage-specific manner: An underlying role of innate immunity in atherosclerosis. Mehta S; Dhawan V Cell Signal; 2020 Aug; 72():109645. PubMed ID: 32305666 [TBL] [Abstract][Full Text] [Related]
23. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow. Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239 [TBL] [Abstract][Full Text] [Related]
24. Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways. Rahman MM; McFadden G J Virol; 2011 Dec; 85(23):12505-17. PubMed ID: 21957307 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate. Yuan X; Wang L; Bhat OM; Lohner H; Li PL Redox Biol; 2018 Jun; 16():21-31. PubMed ID: 29475132 [TBL] [Abstract][Full Text] [Related]
26. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970 [TBL] [Abstract][Full Text] [Related]
27. Exposure of cigarette smoke condensate activates NLRP3 inflammasome in vitro and in vivo: A connotation of innate immunity and atherosclerosis. Mehta S; Srivastava N; Bhatia A; Dhawan V Int Immunopharmacol; 2020 Jul; 84():106561. PubMed ID: 32402952 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines. Köse-Vogel N; Stengel S; Gardey E; Kirchberger-Tolstik T; Reuken PA; Stallmach A; Bruns T Cells; 2019 Dec; 9(1):. PubMed ID: 31905600 [TBL] [Abstract][Full Text] [Related]
29. Defining trained immunity and its role in health and disease. Netea MG; Domínguez-Andrés J; Barreiro LB; Chavakis T; Divangahi M; Fuchs E; Joosten LAB; van der Meer JWM; Mhlanga MM; Mulder WJM; Riksen NP; Schlitzer A; Schultze JL; Stabell Benn C; Sun JC; Xavier RJ; Latz E Nat Rev Immunol; 2020 Jun; 20(6):375-388. PubMed ID: 32132681 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic Epigenetic Reprogramming of Trained Immunity in Myeloid Cells. Rodriguez RM; Suarez-Alvarez B; Lopez-Larrea C Trends Immunol; 2019 Jan; 40(1):66-80. PubMed ID: 30595189 [TBL] [Abstract][Full Text] [Related]
32. The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome. Ren R; Wu S; Cai J; Yang Y; Ren X; Feng Y; Chen L; Qin B; Xu C; Yang H; Song Z; Tian D; Hu Y; Zhou X; Meng G Sci Rep; 2017 Aug; 7(1):7625. PubMed ID: 28790324 [TBL] [Abstract][Full Text] [Related]
33. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Mitroulis I; Ruppova K; Wang B; Chen LS; Grzybek M; Grinenko T; Eugster A; Troullinaki M; Palladini A; Kourtzelis I; Chatzigeorgiou A; Schlitzer A; Beyer M; Joosten LAB; Isermann B; Lesche M; Petzold A; Simons K; Henry I; Dahl A; Schultze JL; Wielockx B; Zamboni N; Mirtschink P; Coskun Ü; Hajishengallis G; Netea MG; Chavakis T Cell; 2018 Jan; 172(1-2):147-161.e12. PubMed ID: 29328910 [TBL] [Abstract][Full Text] [Related]
35. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis. Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536 [TBL] [Abstract][Full Text] [Related]
36. Jagged1-mediated myeloid Notch1 signaling activates HSF1/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Jin Y; Li C; Xu D; Zhu J; Wei S; Zhong A; Sheng M; Duarte S; Coito AJ; Busuttil RW; Xia Q; Kupiec-Weglinski JW; Ke B Cell Mol Immunol; 2020 Dec; 17(12):1245-1256. PubMed ID: 31673056 [TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages. Son S; Hwang I; Han SH; Shin JS; Shin OS; Yu JW J Biol Chem; 2017 Dec; 292(50):20437-20448. PubMed ID: 29051224 [TBL] [Abstract][Full Text] [Related]
38. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway. Zhang H; Gong X; Ni S; Wang Y; Zhu L; Ji N Int Immunopharmacol; 2019 Dec; 77():105934. PubMed ID: 31727560 [TBL] [Abstract][Full Text] [Related]
39. The Effects of Trained Innate Immunity on T Cell Responses; Clinical Implications and Knowledge Gaps for Future Research. Murphy DM; Mills KHG; Basdeo SA Front Immunol; 2021; 12():706583. PubMed ID: 34489958 [TBL] [Abstract][Full Text] [Related]
40. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Pierantonelli I; Rychlicki C; Agostinelli L; Giordano DM; Gaggini M; Fraumene C; Saponaro C; Manghina V; Sartini L; Mingarelli E; Pinto C; Buzzigoli E; Trozzi L; Giordano A; Marzioni M; Minicis S; Uzzau S; Cinti S; Gastaldelli A; Svegliati-Baroni G Sci Rep; 2017 Sep; 7(1):12200. PubMed ID: 28939830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]